development of rna aptamers as molecular probes for her2+ breast cancer study using cell-selex

Authors

seyedeh alia moosavian biotechnology research center, nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran

mahmoud reza jaafari biotechnology research center, nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran

seyed mohammad taghdisi targeted drug delivery research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran

fatemeh mosaffa biotechnology research center, pharmacy school, mashhad university of medical sciences, mashhad, iran

abstract

objective(s): development of molecules that specifically recognize cancer cells is one of the major areas in cancer research. human epidermal growth factor receptor 2 (her2) is specifically expressed on the surface of breast cancer cells. her2 is associated with an aggressive phenotype and poor prognosis. in this study we aimed to isolate rna aptamers that specifically bind to her2 overexpressing tubo cell line. materials and methods: panel of aptamers was selected using cell-based systematic evolution of ligands by exponential enrichment (cell-selex). results: binding studies showed that selected aptamers can identify tubo cell line with high affinity and selectivity. our preliminary investigation of the target of aptamers suggested that aptamers bind with her2 proteins on the surface of tubo cells. conclusion: we believe the selected aptamers could be useful ligands for targeted breast cancer therapy.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Development of RNA aptamers as molecular probes for HER2+ breast cancer study using cell-SELEX

Objective(s): Development of molecules that specifically recognize cancer cells is one of the major areas in cancer research. Human epidermal growth factor receptor 2 (HER2) is specifically expressed on the surface of breast cancer cells. HER2 is associated with an aggressive phenotype and poor prognosis. In this study we aimed to isolate RNA aptamers that specifically bind to HER2 overexpressi...

full text

Development of RNA aptamers as molecular probes for HER2+ breast cancer study using cell-SELEX

OBJECTIVES Development of molecules that specifically recognize cancer cells is one of the major areas in cancer research. Human epidermal growth factor receptor 2 (HER2) is specifically expressed on the surface of breast cancer cells. HER2 is associated with an aggressive phenotype and poor prognosis. In this study we aimed to isolate RNA aptamers that specifically bind to HER2 overexpressing ...

full text

DNA Aptamers as Molecular Probes for Colorectal Cancer Study

BACKGROUND Understanding the molecular features of specific tumors can increase our knowledge about the mechanism(s) underlying disease development and progression. This is particularly significant for colorectal cancer, which is a heterogeneous complex of diseases developed in a sequential manner through a multistep carcinogenic process. As such, it is likely that tumors with similar character...

full text

RAPID-SELEX for RNA Aptamers

Aptamers are high-affinity ligands selected from DNA or RNA libraries via SELEX, a repetitive in vitro process of sequential selection and amplification steps. RNA SELEX is more complicated than DNA SELEX because of the additional transcription and reverse transcription steps. Here, we report a new selection scheme, RAPID-SELEX (RNA Aptamer Isolation via Dual-cycles SELEX), that simplifies this...

full text

Use of Cell-SELEX to Generate DNA Aptamers as Molecular Probes of HPV-Associated Cervical Cancer Cells

BACKGROUND Disease-specific biomarkers are an important tool for the timely and effective management of pathological conditions, including determination of susceptibility, diagnosis, and monitoring efficacy of preventive or therapeutic strategies. Aptamers, comprising single-stranded or double-stranded DNA or RNA, can serve as biomarkers of disease or biological states. Aptamers can bind to spe...

full text

RNA nanotechnology breakthrough for targeted release of RNA-based drugs using cell-based aptamers

Nucleic acids play different roles besides storing information and proteins coding. For example, single-stranded nucleic acids can fold into complicated structures with capability of molecular detection, catalyzing bioreactions and therapy. The development of RNA-based therapies has been rapidly progressed in the recent years. RNA aptamers are biomolecules with a size of 10 to 50 nm that can be...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of basic medical sciences

جلد ۱۸، شماره ۶، صفحات ۵۷۶-۵۸۶

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023